Hideaki Aoyama
- Oncology
- Cancer Research
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Pathology and Forensic Medicine
- Co-authors
- N HorikoshiT TaguchiShu IchiharaS TakashimaMuneaki SanoMorihiko KimuraI AdachiToru Watanabe
- Topics
- Cancer Treatment and Pharmacology (10 papers)Breast Cancer Treatment Studies (9 papers)Breast Lesions and Carcinomas (5 papers)
- Cited by
- OncologyCancer ResearchDermatology
- Partner nations
- Japan
In The Last Decade
Hideaki Aoyama
24 papers receiving 366 citations
Peers
Comparison fields: 5 of 54
- Oncology 218
- Cancer Research 120
- Pulmonary and Respiratory Medicine 77
- Molecular Biology 74
- Pathology and Forensic Medicine 61
Countries citing papers authored by Hideaki Aoyama
This map shows the geographic impact of Hideaki Aoyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Aoyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Aoyama more than expected).
Fields of papers citing papers by Hideaki Aoyama
This network shows the impact of papers produced by Hideaki Aoyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Aoyama. The network helps show where Hideaki Aoyama may publish in the future.
Co-authorship network of co-authors of Hideaki Aoyama
This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Aoyama. A scholar is included among the top collaborators of Hideaki Aoyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Aoyama. Hideaki Aoyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 39 | |
| 3 | 51 | |
| 4 | Combination chemotherapy with docetaxel and doxifluridine showed a beneficial outcome in advanced or recurrent breast cancer patients with longer disease-free interval. | 2 |
| 5 | [CGS 20267 (Letrozole), a new aromatase inhibitor: early phase II study for postmenopausal women with advanced breast cancer]. | 1 |
| 6 | 21 | |
| 7 | 3 | |
| 8 | [Early phase II study of TAT-59 in patients with advanced or recurrent breast cancer--a multicenter dose finding study]. | 1 |
| 9 | [An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)]. | 15 |
| 10 | 78 | |
| 11 | 29 | |
| 12 | 11 | |
| 13 | 10 | |
| 14 | 9 | |
| 15 | 4 | |
| 16 | [A phase II study of DWA2114R, a new platinum complex for breast cancer]. | 3 |
| 17 | [Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy]. | 3 |
| 18 | 4 | |
| 19 | [Establishment and characterization of a tumor marker producing cell line (JR-1) derived from a gastric scirrhous cancer]. | 5 |
| 20 | 3 |
About Hideaki Aoyama
Hideaki Aoyama is a scholar working on Cancer Research, Oncology and Dermatology, having authored 24 papers that have together received 382 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (9 papers) and Breast Lesions and Carcinomas (5 papers). The work is most often cited by research in Oncology (218 citations), Cancer Research (120 citations) and Dermatology (58 citations). Hideaki Aoyama has collaborated with scholars based in Japan. Frequent co-authors include N Horikoshi, T Taguchi, Shu Ichihara, S Takashima, Muneaki Sano, Morihiko Kimura, I Adachi, Toru Watanabe, Masaru Narabayashi and Tokiko Endo. Their work appears in journals such as Cancer, British Journal of Cancer and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.